KONINKLIJKE PHILIPS NV ADR

NYSE: PHG (Koninklijke Philips N.V. NY Reg)

最近更新时间: 昨天, 5:27PM

26.62

-0.39 (-1.44%)

前收盘价格 27.01
收盘价格 26.78
成交量 620,101
平均成交量 (3个月) 763,719
市值 25,315,061,760
市盈率 (P/E TTM) 140.11
预期市盈率 (P/E Forward) 14.12
价格/销量 (P/S) 1.21
股市价格/股市净资产 (P/B) 2.08
52周波幅
21.48 (-19%) — 29.54 (10%)
利润日期 28 Jan 2026
营业毛利率 2.08%
营业利益率 (TTM) 3.78%
稀释每股收益 (EPS TTM) 0.300
季度收入增长率 (YOY) -1.00%
季度盈利增长率 (YOY) 105.70%
总债务/股东权益 (D/E MRQ) 64.54%
流动比率 (MRQ) 1.28
营业现金流 (OCF TTM) 801.00 M
杠杆自由现金流 (LFCF TTM) 1.37 B
资产报酬率 (ROA TTM) 2.01%
股东权益报酬率 (ROE TTM) 1.99%

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 Koninklijke Philips N.V. NY Reg - -

AIStockmoo 评分

-1.3
分析师共识 NA
内部交易活动 NA
价格波动 -2.0
技术平均移动指标 -1.5
技术振荡指标 -0.5
平均 -1.33

相关股票

股票 市值 DY P/E(TTM) P/B
PHG 25 B - 140.11 2.08
BSX 144 B - 51.77 5.81
SYK 139 B 0.46% 47.88 6.20
ABT 218 B 0.47% 15.49 4.18
MDT 135 B 1.33% 28.46 2.63
EW 49 B - 36.95 4.74

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

部门 Healthcare
行业 Medical Devices
投资方式 Large Core
机构持股比例 6.50%

所有权

姓名 日期 持有股份
Exor N.V. 30 Sep 2025 182,543,970
Becker Capital Management Inc 30 Sep 2025 911,185
日期 类型 细节
04 Dec 2025 公告 Philips reiterates timing of 2026 outlook
04 Dec 2025 公告 Philips reiterates timing of 2026 outlook
01 Dec 2025 公告 Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy
01 Dec 2025 公告 Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy
30 Nov 2025 公告 Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
30 Nov 2025 公告 Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
30 Nov 2025 公告 Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
30 Nov 2025 公告 Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
24 Nov 2025 公告 Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere
24 Nov 2025 公告 Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere
19 Nov 2025 公告 Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology
19 Nov 2025 公告 Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology
17 Nov 2025 公告 Philips brings AI into the procedure room to assist doctors during heart valve repair
17 Nov 2025 公告 Philips brings AI into the procedure room to assist doctors during heart valve repair
04 Nov 2025 公告 Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion
04 Nov 2025 公告 Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion
03 Nov 2025 公告 Philips Joins the Forever Promise Project to Honor American Veterans
30 Oct 2025 公告 Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
30 Oct 2025 公告 Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
29 Oct 2025 公告 Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
29 Oct 2025 公告 Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
27 Oct 2025 公告 Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI
27 Oct 2025 公告 Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI
08 Oct 2025 公告 Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide
08 Oct 2025 公告 Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide
07 Oct 2025 公告 UAE Residents embrace proactive, tech-driven, and sustainable healthcare, according to the second edition of Philips Health Trends Research*
26 Sep 2025 公告 Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025
26 Sep 2025 公告 Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025
25 Sep 2025 公告 Philips joins Optum Healthcare’s network as a preferred provider in the USA
25 Sep 2025 公告 Philips joins Optum Healthcare’s network as a preferred provider in the USA
23 Sep 2025 公告 Philips Sonicare unveils next-generation Sonicare technology designed for a gentle, yet effective switch from manual brushing, exclusively at Walmart
23 Sep 2025 公告 Philips Future Health Index Research Finds 1 in 5 Canadians Have Ended Up in Hospital While Awaiting Care
17 Sep 2025 公告 Southlake Health transforms diagnostic imaging with Philips AI-enabled MRI increasing capacity to address patient demand
15 Sep 2025 公告 Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans
15 Sep 2025 公告 Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans
显示更多
5年平均股息收益率 1.78%
除息日 公告日期 支付日期 详情
12 May 2022 07 Jun 2022 08 Jun 2022 0.912092 现金
10 May 2021 25 Jan 2021 09 Jun 2021 1.034025 现金
13 May 2019 19 Apr 2019 13 Jun 2019 0.961222 现金
07 May 2018 31 Jan 2018 06 Jun 2018 0.9394 现金
12 May 2017 - 14 Jun 2017 0.762926 现金
13 May 2016 - 15 Jun 2016 0.766224 现金
08 May 2015 - 10 Jun 2015 0.759016 现金
05 May 2014 - 04 Jun 2014 0.925548 现金
07 May 2013 - 05 Jun 2013 0.82926 现金
02 May 2012 - 31 May 2012 0.801082 现金
04 Apr 2011 - 04 May 2011 0.945859 现金
29 Mar 2010 - 28 Apr 2010 0.792599 现金
30 Mar 2009 - 07 Apr 2009 0.796824 现金
28 Mar 2008 - 07 Apr 2008 1.09424 现金
30 Mar 2007 - 10 Apr 2007 0.80112 现金
31 Mar 2006 - 10 Apr 2006 0.53953 现金
01 Apr 2005 - 11 Apr 2005 0.5144 现金
26 Mar 2004 - 05 Apr 2004 0.44006 现金
28 Mar 2003 - 07 Apr 2003 0.38988 现金
02 Apr 2002 - 08 Apr 2002 0.31709 现金
30 Mar 2001 - 18 Apr 2001 0.31975 现金
27 Jul 2000 - 04 Aug 2000 1.168776 现金
05 Apr 2000 - 19 Apr 2000 1.14288 现金
26 May 1999 - 03 Jun 1999 4.289884 现金
26 Mar 1999 - 14 Apr 1999 1.08717 现金
17 Mar 1998 - 03 Apr 1998 0.9712 现金
24 Mar 1997 - 11 Apr 1997 0.84818 现金
26 Mar 1996 - 16 Apr 1996 0.82155 现金
03 May 1995 - 31 May 1995 0.68192 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2022 0.912 1 6.09
2021 1.03 1 2.81
2019 0.961 1 1.97
2018 0.939 1 2.68
2017 0.763 1 2.02
2016 0.766 1 2.51
2015 0.759 1 2.98
2014 0.926 1 3.19
2013 0.829 1 2.24
2012 0.801 1 3.02
2011 0.946 1 4.52
2010 0.793 1 2.58
2009 0.797 1 2.71
2008 1.09 1 5.51
2007 0.801 1 1.87
2006 0.540 1 1.44
2005 0.514 1 1.65
2004 0.440 1 1.66
2003 0.390 1 1.34
2002 0.317 1 1.79
2001 0.320 1 1.10
2000 2.31 2 6.38
1999 5.38 2 15.93
1998 0.971 1 5.74
1997 0.848 1 5.61
1996 0.822 1 8.22
1995 0.682 1 7.60
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票